Accessible Machine Learning and Deep Learning Models Predict Response and Survival in Early Stage Hormone Receptor-Positive/HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
Preprint in Research Square (March 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Adjuvant Ovarian Function Suppression in Premenopausal Hormone Receptor–Positive Breast Cancer
Article in JAMA Network Open (March 2024)
Cancer therapy–related vaginal toxicity: its prevalence and assessment methods—a systematic review
Article in Journal of Cancer Survivorship (February 2024)